treatment

CME Webcast Discusses The Red Eye Differential Diagnosis and Treatment

by

OSUWexnerbloglogo2014 CME Webcast Discusses The Red Eye: Differential Diagnosis and Treatment. Today on MedNet21, we’re going to review the causes of red eyes in order to help you make a prompt diagnosis and get your patients started on the right treatment. We’re pleased to welcome back Assistant Professor of Ophthalmology, Dr. Tyler Oostra.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: recognize and diagnosis common causes of red eye; and know when to refer patients with red eyes for further care.

You’ll also learn about the following:

  • Most common causes of red eyes
  • Red eye red flags
  • Bacterial versus viral conjunctivitis
  • Isolation of children with viral conjunctivitis
  • When shingles affects the eye
  • Diagnostic significance of bilateral versus unilateral red eye
  • Causes of dry eyes

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Experts Provide An Update on Treatment of COVID-19

by

OSUWexnerbloglogo2014 Experts Provide An Update on Treatment of COVID-19. The pandemic is bad now but it is projected to get even worse over the next months. Many physicians, nurse practitioners, and physician assistants are going to be called on to care for patients with COVID-19 and we want to be sure that you have to tools you need to provide the best possible care for your patients. On this CME webcast, welcome back to MedNet21 two veteran presenters about the COVID-19 outbreak. Dr. Michael Haden is an Assistant Professor of Internal Medicine from the Division of Infectious Disease at the Ohio State University. And Dr. Rachel Quaney is a pulmonologist and Clinical Instructor of Internal Medicine at Ohio State.


What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW infection control measures necessary regarding SARS-CoV-2; PROVIDE update on current treatment recommendations for COVID-19; EVALUATE a patient with respiratory failure from COVID-19; and DISCUSS the risk factors for SARS-CoV-2 transmission as well as the risk factors for severe COVID-19.

You’ll also learn about the following:

  • Improvements in the treatment of COVID-19
  • Changes in the ICU management of COVID-19
  • COVID-19 vaccine safety

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Provides Understanding of Suboxone Treatment

by

OSUWexnerbloglogo2014 On-line Education Provides Understanding of Suboxone Treatment. On this CME webcast, we are going to examine how buprenorphine and Suboxone fit into the management of the opioid-addicted patient in the hospital. To tell us how this works in the emergency department is Assistant Professor of Internal Medicine and Emergency Medicine, Dr. Emily Kauffman. And to tell us about medication assisted treatment for inpatients is hospitalist and Assistant Professor of Internal Medicine, Dr. Margaret Williams.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: EXPLAIN why Medications-Assisted Treatment (MAT), specifically buprenorphine (suboxone) is effective for treatment of Opioid Use Disorder; DESCRIBE the importance of addressing opioid use disorder in all patient encounters, beginning with the Emergency Department.

You’ll also learn about the following:

  • The role of the emergency department in treating opioid addiction
  • The role of medication assisted therapy in hospitalized patients
  • Project DAWN
  • RREACT
  • Management of opioid-dependent patients who are NPO
  • DEA-X waivers

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Treatments for Osteoporosis

by

OSUWexnerbloglogo2014 Learn About New Treatments for Osteoporosis. On this CME webcast, we’re going to bring you up to date on the latest recommendations for the management of osteoporosis and on the latest developments in pharmacologic treatment. Joining our moderator in the studio is endocrinologist and Associate Professor of Internal Medicine, Dr. Steven Ing. And endocrinologist and also Associate Professor of Internal Medicine, Dr. Laura Ryan.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS 2017 ACP guidelines on osteoporosis; DISCUSS studies subsequent to guidelines; UNDERSTAND the latest data on therapy for postmenopausal osteoporosis using evidence based clinical studies; and IMPROVE comfort in deciding on initial therapy to choose for patients at high risk for fracture, then monitoring that choice over time.

You’ll also learn about the following:

  • New developments in osteoporosis treatment
  • Choosing a bisphosphonate
  • Calcium & vitamin D

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Managing Complications of Chemotherapy Discussed on CME Webcast

by

OSUWexnerbloglogo2014 Managing Complications of Chemotherapy Discussed on CME Webcast. On this CME webcast, to update us is medical oncologist and Associate Professor of Internal Medicine from the Ohio State University and the James Cancer Hospital, Dr. Erin Bertino. And also from the James Cancer Hospital, Assistant Professor of Internal Medicine, Dr. Edmund Folefac.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the differences in toxicity for three categories of oncology therapy: cytotoxic chemotherapy, targeted therapy, and immunotherapy; and UNDERSTAND basic management of the most common toxicities of chemotherapy, targeted therapy, and immunotherapy.

You’ll also learn about the following:

  • Evolution of targeted therapies and immunotherapy
  • What to expect with cancer treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.